阿空空
Lv6
2730 积分
2022-10-31 加入
-
Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method
8个月前
已完结
-
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M4 Muscarinic Acetylcholine Receptor
9个月前
已完结
-
UDP-glucuronosyltransferases: Structure, Function and Drug Design Studies
11个月前
已完结
-
Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study
11个月前
已完结
-
The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation
11个月前
已完结
-
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1年前
已完结
-
Pharmacokinetics and Pharmacodynamic of Alpelisib
1年前
已完结
-
Baxdrostat: An Aldosterone Synthase Inhibitor for the Treatment of Systemic Hypertension
1年前
已完结
-
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
1年前
已完结
-
Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients
1年前
已完结